Top Markets
Coin of the day
Taro Pharmaceutical Industries Ltd. Taro Pharmaceutical Industries Ltd.

Taro Pharmaceutical Industries Ltd.

TARO
Rank in Stocks #7358
Taro Pharmaceutical Industries Ltd. operates as a scientifically-driven... Taro Pharmaceutical Industries Ltd. operates as a scientifically-driven pharmaceutical enterprise, specializing in the development, manufacturing, and commercialization of both prescription and over-the-counter medications. Its market reach spans the United States, Canada, Israel, and various other international territories. The company also produces active pharmaceutical ingredients (APIs), primarily for integration into its own finished dosage form products. Its extensive product catalog addresses a broad spectrum of medical conditions and therapeutic areas, encompassing treatments for allergies, pain (analgesic), bacterial and fungal infections (antibacterial, antibiotic, antifungal), seizures (anticonvulsant), nausea (antiemetic), inflammation (anti-inflammatory), cancer (anti-cancer, topical anti-neoplastic), blood clot prevention (antiplatelet agent), fever reduction (antipyretic), cardiovascular issues, central nervous system disorders, hormonal regulation (corticosteroid, endocrine), cosmetic applications, coughs and colds, dermatological complaints, fluid management (diuretic), gastrointestinal problems, constipation (laxative), severe pain (narcotics), neuropathic pain, neuropsychiatric conditions, and sleep/anxiety management (sedative/hypnotic). These pharmaceutical goods are available in numerous formats, including capsules, creams, drops, emulsions, gels (and gel kits), granules, injectables, lotions, oils, ointments, pastes, powders (and powders for solution), rectal suppositories, shampoos, solutions (and solutions for infusion), sprays, suspensions, syrups, tablets, toothpastes and mouthwashes, topical foams, and topical solutions. Taro distributes and sells its products directly to a wide array of clients, such as pharmaceutical wholesalers, retail drug store chains, food chains, hospitals, mass merchandisers, grocery chains, other direct purchasers, and various healthcare institutions and private pharmacies. The company was established in 1950, with its main offices situated in Haifa, Israel. Taro Pharmaceutical Industries Ltd. is a wholly-owned subsidiary of Alkaloida Chemical Company Exclusive Group Ltd.
Share Price
$42.98
Last synced: 2024-06-21
Market Cap
$1.62B
Change (1 day)
0.01%
Change (1 year)
0.00%
Country
IL
Trade Taro Pharmaceutical Industries Ltd. (TARO)

Category

Earnings for Taro Pharmaceutical Industries Ltd. (TARO)
Earnings in Mar 2024 TTM: $82.67M
According to Taro Pharmaceutical Industries Ltd. latest financial reports the company's current earnings are $82.67M. In 2023 the company made an earning of $38.21M, a decrease compared to its 2022 earnings that were of $77.86M. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Earnings history for Taro Pharmaceutical Industries Ltd. from 1999 to 2026
Earnings at the end of each year
Year Earnings Change
2026 (TTM) $82.67M 0.00%
2024 $82.67M 116.33%
2023 $38.21M -50.92%
2022 $77.86M -119.91%
2021 $-391.07M -231.35%
2020 $297.73M -16.57%
2019 $356.85M 22.06%
2018 $292.37M -47.87%
2017 $560.80M -11.94%
2016 $636.82M 9.48%
2015 $581.68M 31.04%
2014 $443.91M 32.17%
2013 $335.86M 39.40%
2012 $240.93M 219.63%
2010 $75.38M 60.06%
2009 $47.09M 6.88%
2008 $44.06M 8.67%
2007 $40.55M -149.57%
2006 $-81.81M -1,221.57%
2005 $7.29M -205.21%
2004 $-6.93M -109.50%
2003 $72.96M 37.75%
2002 $52.96M 74.37%
2001 $30.37M 141.72%
2000 $12.57M 79.24%
1999 $7.01M 0.00%
Earnings for similar companies or competitors